6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells
- Autores
- Thomasz, Lisa; Oglio, Andrea Romina; Rossich, Luciano Esteban; Villamar, Sonia; Perona, Marina; Salvarredi, Leonardo Andres; Dagrosa, María Alejandra; Pisarev, Mario Alberto; Juvenal, Guillermo Juan
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: IL-δ (5-hydroxy-6 iodo-8, 11, 14-eicosatrienoic delta lactone) an iodinated arachidonic acid (AA) derivative, is one of the iodolipids biosynthesized by the thyroid. Although IL-δ regulates several thyroid parameters such as cell proliferation and goiter growth it was found that this iodolipid inhibits the growth of other non thyroid cell lines. Objectives: to study the effect of IL-δ on cell proliferation and apoptosis in the colon cancer cell line HT-29. Results: Treatment with IL-δ reduced cell viability in a concentration-dependent manner: 1μM 20%, 5 μM 25%, 10 μM 31 %, 50 μM 47% and caused a significant decrease of PCNA expression (25%). IL-δ had pro-apoptotic effects, evidenced by morphological features of programmed cell death such as: pyknosis, karyorrhexis, cell shrinkage and cell blebbing observed by fluorescence microscopy, an increase in caspase-3 activity and in Bax/Bcl-2 ratio (2.5 after 3 h of treatment). Furthermore, IL-δ increased ROS production (30%) and lipid peroxidation levels (19 %), suggesting that apoptosis could be a result of increased oxidative stress. A maximum increase in c-fos and c-jun protein expression in response to IL-δ was observed 1 h after initiation of the treatment. Treatment with IL-δ blocked HT-29 xenografts growth in nude mice by more than 70% compared with the control group. Conclusion: our study shows that IL-δ inhibits cell growth and induces apoptosis in the colon cancer cell line, HT-29 and opens the possibility that IL-δ could be a potential useful chemotherapy agent.
Fil: Thomasz, Lisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Oglio, Andrea Romina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Rossich, Luciano Esteban. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina
Fil: Villamar, Sonia. Comisión Nacional de Energía Atómica; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina
Fil: Perona, Marina. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Salvarredi, Leonardo Andres. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Dagrosa, María Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Pisarev, Mario Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Juvenal, Guillermo Juan. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
IODOLIPIDS
IODOLACTONE
ARACHIDONIC ACID
COLON CANCER - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/104121
Ver los metadatos del registro completo
id |
CONICETDig_3f74288e492721a835c9a407009350f8 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/104121 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cellsThomasz, LisaOglio, Andrea RominaRossich, Luciano EstebanVillamar, SoniaPerona, MarinaSalvarredi, Leonardo AndresDagrosa, María AlejandraPisarev, Mario AlbertoJuvenal, Guillermo JuanIODOLIPIDSIODOLACTONEARACHIDONIC ACIDCOLON CANCERhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Background: IL-δ (5-hydroxy-6 iodo-8, 11, 14-eicosatrienoic delta lactone) an iodinated arachidonic acid (AA) derivative, is one of the iodolipids biosynthesized by the thyroid. Although IL-δ regulates several thyroid parameters such as cell proliferation and goiter growth it was found that this iodolipid inhibits the growth of other non thyroid cell lines. Objectives: to study the effect of IL-δ on cell proliferation and apoptosis in the colon cancer cell line HT-29. Results: Treatment with IL-δ reduced cell viability in a concentration-dependent manner: 1μM 20%, 5 μM 25%, 10 μM 31 %, 50 μM 47% and caused a significant decrease of PCNA expression (25%). IL-δ had pro-apoptotic effects, evidenced by morphological features of programmed cell death such as: pyknosis, karyorrhexis, cell shrinkage and cell blebbing observed by fluorescence microscopy, an increase in caspase-3 activity and in Bax/Bcl-2 ratio (2.5 after 3 h of treatment). Furthermore, IL-δ increased ROS production (30%) and lipid peroxidation levels (19 %), suggesting that apoptosis could be a result of increased oxidative stress. A maximum increase in c-fos and c-jun protein expression in response to IL-δ was observed 1 h after initiation of the treatment. Treatment with IL-δ blocked HT-29 xenografts growth in nude mice by more than 70% compared with the control group. Conclusion: our study shows that IL-δ inhibits cell growth and induces apoptosis in the colon cancer cell line, HT-29 and opens the possibility that IL-δ could be a potential useful chemotherapy agent.Fil: Thomasz, Lisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Oglio, Andrea Romina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Rossich, Luciano Esteban. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; ArgentinaFil: Villamar, Sonia. Comisión Nacional de Energía Atómica; Argentina. Universidad de Buenos Aires. Facultad de Medicina; ArgentinaFil: Perona, Marina. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Salvarredi, Leonardo Andres. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Dagrosa, María Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Pisarev, Mario Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Juvenal, Guillermo Juan. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaElsevier2013-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/104121Thomasz, Lisa; Oglio, Andrea Romina; Rossich, Luciano Esteban; Villamar, Sonia; Perona, Marina; et al.; 6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells; Elsevier; Prostaglandins Leukotrienes and Essential Fatty Acids; 88; 4; 4-2013; 273-2800952-3278CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.plefa.com/article/S0952-3278(13)00004-5/fulltextinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.plefa.2013.01.002info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:10:09Zoai:ri.conicet.gov.ar:11336/104121instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:10:09.374CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
title |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
spellingShingle |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells Thomasz, Lisa IODOLIPIDS IODOLACTONE ARACHIDONIC ACID COLON CANCER |
title_short |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
title_full |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
title_fullStr |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
title_full_unstemmed |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
title_sort |
6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells |
dc.creator.none.fl_str_mv |
Thomasz, Lisa Oglio, Andrea Romina Rossich, Luciano Esteban Villamar, Sonia Perona, Marina Salvarredi, Leonardo Andres Dagrosa, María Alejandra Pisarev, Mario Alberto Juvenal, Guillermo Juan |
author |
Thomasz, Lisa |
author_facet |
Thomasz, Lisa Oglio, Andrea Romina Rossich, Luciano Esteban Villamar, Sonia Perona, Marina Salvarredi, Leonardo Andres Dagrosa, María Alejandra Pisarev, Mario Alberto Juvenal, Guillermo Juan |
author_role |
author |
author2 |
Oglio, Andrea Romina Rossich, Luciano Esteban Villamar, Sonia Perona, Marina Salvarredi, Leonardo Andres Dagrosa, María Alejandra Pisarev, Mario Alberto Juvenal, Guillermo Juan |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
IODOLIPIDS IODOLACTONE ARACHIDONIC ACID COLON CANCER |
topic |
IODOLIPIDS IODOLACTONE ARACHIDONIC ACID COLON CANCER |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Background: IL-δ (5-hydroxy-6 iodo-8, 11, 14-eicosatrienoic delta lactone) an iodinated arachidonic acid (AA) derivative, is one of the iodolipids biosynthesized by the thyroid. Although IL-δ regulates several thyroid parameters such as cell proliferation and goiter growth it was found that this iodolipid inhibits the growth of other non thyroid cell lines. Objectives: to study the effect of IL-δ on cell proliferation and apoptosis in the colon cancer cell line HT-29. Results: Treatment with IL-δ reduced cell viability in a concentration-dependent manner: 1μM 20%, 5 μM 25%, 10 μM 31 %, 50 μM 47% and caused a significant decrease of PCNA expression (25%). IL-δ had pro-apoptotic effects, evidenced by morphological features of programmed cell death such as: pyknosis, karyorrhexis, cell shrinkage and cell blebbing observed by fluorescence microscopy, an increase in caspase-3 activity and in Bax/Bcl-2 ratio (2.5 after 3 h of treatment). Furthermore, IL-δ increased ROS production (30%) and lipid peroxidation levels (19 %), suggesting that apoptosis could be a result of increased oxidative stress. A maximum increase in c-fos and c-jun protein expression in response to IL-δ was observed 1 h after initiation of the treatment. Treatment with IL-δ blocked HT-29 xenografts growth in nude mice by more than 70% compared with the control group. Conclusion: our study shows that IL-δ inhibits cell growth and induces apoptosis in the colon cancer cell line, HT-29 and opens the possibility that IL-δ could be a potential useful chemotherapy agent. Fil: Thomasz, Lisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: Oglio, Andrea Romina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: Rossich, Luciano Esteban. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina Fil: Villamar, Sonia. Comisión Nacional de Energía Atómica; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina Fil: Perona, Marina. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Salvarredi, Leonardo Andres. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Dagrosa, María Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: Pisarev, Mario Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: Juvenal, Guillermo Juan. Comisión Nacional de Energía Atómica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Background: IL-δ (5-hydroxy-6 iodo-8, 11, 14-eicosatrienoic delta lactone) an iodinated arachidonic acid (AA) derivative, is one of the iodolipids biosynthesized by the thyroid. Although IL-δ regulates several thyroid parameters such as cell proliferation and goiter growth it was found that this iodolipid inhibits the growth of other non thyroid cell lines. Objectives: to study the effect of IL-δ on cell proliferation and apoptosis in the colon cancer cell line HT-29. Results: Treatment with IL-δ reduced cell viability in a concentration-dependent manner: 1μM 20%, 5 μM 25%, 10 μM 31 %, 50 μM 47% and caused a significant decrease of PCNA expression (25%). IL-δ had pro-apoptotic effects, evidenced by morphological features of programmed cell death such as: pyknosis, karyorrhexis, cell shrinkage and cell blebbing observed by fluorescence microscopy, an increase in caspase-3 activity and in Bax/Bcl-2 ratio (2.5 after 3 h of treatment). Furthermore, IL-δ increased ROS production (30%) and lipid peroxidation levels (19 %), suggesting that apoptosis could be a result of increased oxidative stress. A maximum increase in c-fos and c-jun protein expression in response to IL-δ was observed 1 h after initiation of the treatment. Treatment with IL-δ blocked HT-29 xenografts growth in nude mice by more than 70% compared with the control group. Conclusion: our study shows that IL-δ inhibits cell growth and induces apoptosis in the colon cancer cell line, HT-29 and opens the possibility that IL-δ could be a potential useful chemotherapy agent. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/104121 Thomasz, Lisa; Oglio, Andrea Romina; Rossich, Luciano Esteban; Villamar, Sonia; Perona, Marina; et al.; 6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells; Elsevier; Prostaglandins Leukotrienes and Essential Fatty Acids; 88; 4; 4-2013; 273-280 0952-3278 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/104121 |
identifier_str_mv |
Thomasz, Lisa; Oglio, Andrea Romina; Rossich, Luciano Esteban; Villamar, Sonia; Perona, Marina; et al.; 6 Iodo-d-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells; Elsevier; Prostaglandins Leukotrienes and Essential Fatty Acids; 88; 4; 4-2013; 273-280 0952-3278 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.plefa.com/article/S0952-3278(13)00004-5/fulltext info:eu-repo/semantics/altIdentifier/doi/10.1016/j.plefa.2013.01.002 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270108519497728 |
score |
13.13397 |